Analgesics - Southeast Asia | Statista Market Forecast

The revenue in the Analgesics market in Southeast Asia amounts to US$1.56bn in 2024.
It is projected to grow annually by 8.79% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, with US$7.24bn in 2024.
Taking into account the total population, per person revenues of US$2.26 are generated in Southeast Asia in 2024.
The demand for over-the-counter analgesics is on the rise in Southeast Asian countries like Indonesia, driven by increasing urbanization and the growing middle-class population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Southeast Asia is experiencing steady growth due to increasing customer preferences for pain relief medications, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Southeast Asia are driving the growth of the Analgesics market. As the population in the region continues to grow, there is a higher demand for pain relief medications. This is due to various factors such as an aging population, increasing prevalence of chronic diseases, and a higher awareness of the importance of self-care and pain management. Customers in Southeast Asia are seeking effective and convenient solutions to relieve their pain, leading to an increased demand for analgesics.Trends in the Analgesics market are also contributing to its growth in Southeast Asia. One major trend is the shift towards natural and herbal analgesics. Customers in the region are becoming more conscious of the potential side effects of traditional analgesics and are seeking alternative options. This has led to the rise of natural and herbal analgesics, which are perceived to be safer and have fewer side effects. Manufacturers are capitalizing on this trend by introducing new products that cater to the growing demand for natural and herbal analgesics.Another trend in the market is the increasing availability of analgesics through e-commerce platforms. Southeast Asia has seen a rapid growth in e-commerce, with more customers turning to online platforms for their shopping needs. This includes purchasing analgesics, which provides convenience and accessibility for customers. E-commerce platforms also offer a wider range of products and competitive pricing, making it an attractive option for customers looking for analgesics.Local special circumstances in Southeast Asia are also driving the growth of the Analgesics market. The region has a diverse population with different cultural backgrounds and healthcare practices. Traditional medicine, such as herbal remedies, is deeply rooted in the culture of many Southeast Asian countries. This has created a unique market for herbal analgesics, as customers prefer products that align with their cultural beliefs and practices. Manufacturers have recognized this preference and are developing and promoting herbal analgesics specifically for the Southeast Asian market.Underlying macroeconomic factors further contribute to the growth of the Analgesics market in Southeast Asia. The region has been experiencing steady economic growth, resulting in an increase in disposable income and purchasing power. As customers have more money to spend, they are willing to invest in their health and well-being, including purchasing analgesics. Additionally, the increasing urbanization and modernization in Southeast Asia have led to lifestyle changes, such as sedentary jobs and increased stress levels, which contribute to the demand for analgesics.In conclusion, the Analgesics market in Southeast Asia is growing due to customer preferences for pain relief medications, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. As the region continues to develop and evolve, the demand for analgesics is expected to increase, providing opportunities for manufacturers and suppliers in the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.